Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
4 minute read

Cellectis Announces Pricing Of Follow-On $20.2M Public Offering Of 8.8M American Depositary Shares At A Price Of $2.50/ADS; Plans To Use ~$17M Of Proceeds To Fund The Continued Clinical Development Of UCART 123, UCART22, UCART20x22, And UCARTCS1

By Happy Mohamed
Today, 11:48 PM
Cellectis S.A. ("Cellectis" or the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announces

CLLS

Read More
1 minute read

Reported Late Thursday, Avalo Therapeutics Announces Pricing Of $15M Public Offering Of 3.77M Shares Of Common Stock And Warrants To Purchase 3.77M Shares Of Stock At A Price Of $3.98/ Share & Warrant, 1-Year Term Excursive Price Of $5/Share

By Happy Mohamed
Today, 11:48 PM
Avalo Therapeutics, Inc. (NASDAQ:AVTX) (Avalo) announced today the pricing of an underwritten public offering of 3,770,000 shares of its common stock and warrants to purchase up to an aggregate of 3,770,000 shares

AVTX

Read More
1 minute read

Reported Late Thursday, Edible Garden Announces Pricing Of Upsized $10.2M Public Offering Of 1,619,000 Units, Each Unit Consisting Of One Share Of Stock And One Warrant At A Price Of $6.30/Unit; Warrants In The Units Will Be Immediately Exercisable

By Happy Mohamed
Today, 11:48 PM
Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)))), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce andEdible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)))), a

EDBL

Read More
1 minute read

Vera Vera Therapeutics Late Wednesday Announced Pricing Of ~!4.28M Share Public Offering of Class A Common Stock @$7/Share

By Charles Gross
Today, 11:48 PM
Vera Therapeutics, Inc., (NasdaqGM: VERA) announced the pricing of its previously announced underwritten public offering of 14,285,715 shares of its Class A common stock at a price to the public of $7.00 per share. The gross proceeds to Vera from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $100.0 million.

VERA